Posts Tagged: 2004
A research scientist examines a capsule with a DNA double helix. (Photo: Dan Race, via Shutterstock)
One year ago this month, a $5.5 billion wave washed over California’s ambitious stem cell agency and left it refreshed and renewed for another decade or so of searching for “miraculous” treatments for a host of deadly, incurable afflictions. It is now on a pace to hand out $38,000 an hour, 24 hours a day, seven days a week. That would amount to $519 million in awards between this time last year and the end of the agency’s current fiscal year in June.
Two of the members of the CIRM governing board, Chair Jon Thomas and Vice Chair Art Torres, during an earlier meeting.(Photo: CIRM)
Directors of the $12 billion California stem cell agency have moved to weaken conflict of interest provisions affecting its governing board — eliminating “leave-the-room” requirements that are used by most private nonprofits to assure the integrity of their operations.
California Gov. Gavin Newsom just before a meeting in Sacramento. ((Photo: Matt Gush, cvia Shutterstock)
Gov. Gavin Newsom, long a supporter of the California stem cell agency, today endorsed Proposition 14, the November ballot measure to give the agency $5.5 billion more and save it from financial extinction.
Personnel at UCSF's facility in Fresno, which may benefit if Proposition 14 is approved. (Photo: UCSF)
Proposition 14, the fall ballot measure to save California’s stem cell agency from financial extinction, contains much, much more than the $5.5 billion that it is seeking from the state’s voters. Added to the agency’s charter would be research involving mental health, “therapy delivery,” personalized medicine and “aging as a pathology.“ That is not to mention a greater emphasis on supporting “vital research opportunities” that are not stem cell-related.
DNA is injected into a stem cell. (Photo: Spectral-Design, via Shuttertock)
The California stem cell agency has just finished pumping $5.3 million into the fight to save the lives of Covid-19 victims. And — in a ballot-box bonus — its efforts are already surfacing in the ballot campaign to rescue the agency from its own demise. The agency is running out of money. It will begin closing its doors this fall without major financial support that it hopes will come from Proposition 14, a $5.5 billion bond measure on the November ballot.
A researcher handles a liquid nitrogen bank containing suspended stem cells. (Photo: Elena Pavlovich, via Shutterstock)
OPINION: In our new financial reality, our state and you as voters are faced with tough decisions. Come November, you will decide the fate of California’s stem cell institute. This decision has never been more important to the future of California’s health care, for the patients and their families, than it is now.
A cancer stem cell researcher in the laboratory. (Photo: science photo, via Shutterstock)
A $5.5 billion stem cell bond measure qualified this afternoon for the November ballot, but the campaign to win voter approval is facing an array of hurdles that its supporters never envisioned last summer when they were formulating the initiative.
A signature gatherer in Ventura during the 2018 election cycle. (Photo: Michael Gordon, via Shutterrstock)
Backers of a $5.5 billion stem cell research initiative in California have suspended their efforts to gather signatures to place it on the November ballot, but are expressing confidence that the proposal will qualify. The campaign said it had run afoul of statewide bans on public gatherings.
A laboratory stem cell researcher uses a laptop in conjunction with a microscope. (Photo: moreimages, via Shutterstock)
A small firm in Menlo Park, Ca., is probably the only company in the nation that is named after the number of a particular human protein. It is a small number too, only 47. But it has large implications for California’s financially strapped state stem cell agency.
A pipette and vessels usd in stem cell research. (Photo: CI Photos, via Shutterstock)
The price tag for refinancing California’s unique and ambitious stem cell research program could run to close to $7.8 billion, give or take a few hundred million dollars or more. So says the state’s legislative analyst in a financial analysis of a proposed ballot initiative that is likely to be on next November’s ballot.